Statistical Development of Posaconazole Smedds via D-Optimal Mixture Design under a QBD Paradigm
International Journal of Life Science and Pharma Research · 02.11.2026
DOI: 10.22376/ijlpr.v16i3.2038 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Life Science and Pharma Research, online erschienen am 02.11.2026. Verfasst von Pooja Jupally und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Introduction
Posaconazole is a class II BCS (Biopharmaceutical Classification System) antifungal drug. Current study objective is to enhance solubility by formulating SMEDDS guided by QbD via experimental design.
Methods
Solubility studies in surfactants, oils, and co-surfactants were conducted. Critical quality attributes (CQA), emulsification time (R1) and drug release (R2) were taken as dependent factors. Formulations were prepared as per d-optimal mixture design and evaluated for physico-chemical parameters and dissolution studies.
Results
Maximum solubility 6.953mg/ml in Tween 40, 1.630mg/ml in Transcutol & 0.187mg/ml in Capmul MCM were selected as surfactant, co-surfactant and oil phases. Excipient compatibility was confirmed by FTIR studies. Soluplus was used as Precipitation Inhibitor. Independent factors and dependent factors were mathematically co-related by Linear model and cubic model. From Overlay plots OF1 formulation (43.30ml Capmul MCM, 20ml Tween 40, 36.69ml Transcutol) with desirability co-efficient 0.991 was optimised. This formulation Globule size is 62.7nm, PDI 0.08 and Zeta-potential -0.19 mV.
Discussion
Quality target product profile was postulated and CQA assessed by experimental design. Oil, Capmul MCM influenced rate of emulsification positively but decreased drug release. Surfactant and co-surfactant increased drug release but slowed emulsification time. D-Optimal mixture design was validated by correlation co-efficient of approx. 0.9 between predicted and actual responses. Formulations followed Fickian diffusion mechanism and were stable for one month at 40°C/75% RH.
Conclusion
Posaconazole solubility as SMEDDS has been enhanced.
Zitieren
APA
Jupally, P., Sagarla, U., Devireddy, V., Malladi, J. L., Shaik, N. B., & Domaraju, P. (2026). Statistical Development of Posaconazole Smedds via D-Optimal Mixture Design under a QBD Paradigm. International Journal of Life Science and Pharma Research. https://doi.org/10.22376/ijlpr.v16i3.2038
Vancouver
Jupally P, Sagarla U, Devireddy V, Malladi JL, Shaik NB, Domaraju P. Statistical Development of Posaconazole Smedds via D-Optimal Mixture Design under a QBD Paradigm. International Journal of Life Science and Pharma Research. 2026. doi:10.22376/ijlpr.v16i3.2038
BibTeX
@article{Jupally2026,
author = {Jupally, Pooja and Sagarla, Usharani and Devireddy, Vasavi and Malladi, Jaya Lakshmi and Shaik, Naseeb Basha and Domaraju, Prasanthi},
title = {Statistical Development of Posaconazole Smedds via D-Optimal Mixture Design under a QBD Paradigm},
journal = {International Journal of Life Science and Pharma Research},
year = {2026},
doi = {10.22376/ijlpr.v16i3.2038}
}
EUVIMED